Where does JDS Therapeutics, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), JDS Therapeutics, LLC ranks #17,804 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does JDS Therapeutics, LLC hold?

JDS Therapeutics, LLC holds 16 US utility patents granted between 2015 and 2024, spanning 5 technology areas.

What is JDS Therapeutics, LLC's Innovation Score?

JDS Therapeutics, LLC has an Innovation Score of 33.6 out of 100 (45th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does JDS Therapeutics, LLC focus on?

JDS Therapeutics, LLC's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 16 patents, ranking #1,413 of 7,163 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is JDS Therapeutics, LLC's patent grant rate increasing or decreasing?

JDS Therapeutics, LLC's recent grant velocity is -40% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for JDS Therapeutics, LLC's patents?

JDS Therapeutics, LLC's patents average 12.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the JDS Therapeutics, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

JDS Therapeutics, LLC

USPTO PatentsView assignee record - 16 granted patents across 5 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, JDS ranks #17,804 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 5 technology areas.

#17,804
of 49,997 US assignees by volume: 45th percentile
by Innovation Score (33.6/100): 12.7
avg claims per patent: -40%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R17804 · US Corporation #17,804 · 16 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 16 grants
MID-PACK #17,804/49,997
PHOTO-FINISH Jacobio Pharmaceutic…
CPC-NARROW A61K · 5 areas
INNOV-THIN 33.6/100
CLAIMS-RICH 12.7 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -40% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Jacobio Pharmaceuticals Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How JDS’s 33.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.8 pts (29%) Velocity 8.3 pts (25%) Breadth 7.9 pts (24%) Claim depth 7.6 pts (23%)

Qualcomm Incorporated · highest

85
JDS Therapeutics · this assignee

34
3D Lighting… · lowest

7

What this shows JDS's Innovation Score is 33.6/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for JDS?

Each dot is one of JDS’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). JDS’s own 12.7 claims/patent is ABOVE the 9.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

JDS vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where JDS's grants concentrate

JDS Therapeutics, LLC is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2015 (4 grants) versus a trough of 1 in 2016. By volume, JDS sits between Jacobio Pharmaceuticals Co., Ltd. and Joanneum Research Forschungsgesellschaft MBH.

JDS's three-year grant acceleration

JDS Therapeutics, LLC shows 5 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Jacobio Pharmaceu…

16
Japan Materials

16
Japan Lifeline

16
Japan Vilene

16
Jenetric

16
Jgmg Bengochea

16
Jiangsu Goldwind…

16
Joanneum Research…

16
JDS Therapeutics ◀

16

What this shows JDS holds 16 patents at rank #17,801, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near JDS

By rank, the assignees closest to #17,801 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in JDS's primary technology class.

JDS's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 45th percentile higher than 45% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

JDS Therapeutics, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	25.0%
2016	1	6.3%
2017	2	12.5%
2019	3	18.8%
2021	1	6.3%
2022	1	6.3%
2023	3	18.8%
2024	1	6.3%

Which technologies does JDS Therapeutics, LLC patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 16

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 16

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 12

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 9

Y02A - Technologies FOR Adaptation TO Climate Change 5

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

JDS Therapeutics, LLC's patent record in context - here's where to go next.

JDS Therapeutics, LLC's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #17,804 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare JDS Therapeutics, LLC against Jacobio Pharmaceuticals Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.